Navigation Links
PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
Date:8/28/2007

- Company Plans Sale of Commercial Operations -

- Nuvion(R) Pivotal Trial Program Terminated -

- Company Plans Organizational Realignment -

FREMONT, Calif., Aug. 28 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced a significant strategic change to focus the company on the discovery and development of novel antibodies in oncology and select immunological diseases, following a months-long business and portfolio review.

As a result of this new strategic focus, which does not include cardiovascular disease, PDL plans to sell its commercial assets, including its Cardene(R), Retavase(R) and IV Busulfex(R) products, as well as the ularitide development-stage cardiovascular product. Separately, following a recent and routine Data Monitoring Committee (DMC) evaluation of data from the ongoing RESTORE 1 pivotal trial, the company has decided to terminate the Nuvion (visilizumab) phase 3 program in ulcerative colitis due to insufficient efficacy and an inferior safety profile in the visilizumab arm compared to IV steroids alone. In light of these developments, the company will realign its organization this Fall to support its new strategy.

The company will hold a conference call on Tuesday, August 28th at 5:15 pm ET to discuss these decisions and respond to questions. A webcast of the conference call will be available through the PDL website: http://www.pdl.com.

"We believe our planned strategic shift, which leverages our core technical strengths and expertise in monoclonal antibodies as a development-stage company, is in the best long-term interests of our stockholders," said L.
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015 CytomX, a biotechnology ... today announced that Sean McCarthy , D. Phil., ... Antibody Day in New York ... McCarthy will present an overview of CytomX,s Probody pipeline, ... conjugate programs. About CytomX Therapeutics CytomX ...
(Date:5/5/2015)... WASHINGTON , May 5, 2015  Indianapolis-based ... adoption of its innovative line of products including ... solution for atraumatically accessing deep-seated brain abnormalities and ... have been completed at more than 50 institutions ... The technology has also been included in 12 ...
(Date:5/4/2015)... JSS Medical Research Inc., a Montreal based ... of Max Neeman International (MNI), with head office in ... Ahmedabad, Bangalore , Chennai ... regional office is located North Carolina, USA . ... equity investment transaction into JSS with Capital Croissance PME (CCPME), a ...
(Date:5/4/2015)... - Fluorinov Pharma (Fluorinov), a FACIT portfolio company, ... Roger J Garceau, to its Board of Directors. ... including corporate development and clinical strategy, his appointment ... expertise as Fluorinov transitions to clinical development.  ... pharmaceutical development experience to Fluorinov and most recently ...
Breaking Biology Technology:NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 2NICO Corporation Gains Market Expansion after Multiple Published Clinical Articles Support Access Technology for Deep Brain Lesions 3JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4Roger J Garceau joins Fluorinov board, adds clinical expertise to bromodomain program and oncology pipeline 2Roger J Garceau joins Fluorinov board, adds clinical expertise to bromodomain program and oncology pipeline 3
... 3, 2011 Vermillion, Inc. (NASDAQ: ... received a notice of allowance from the United States Patent ... of biomarkers that could be used in the diagnosis of ... of heart attack and stroke. The patent, entitled ...
... HOPKINTON, Mass., Nov. 3, 2011 Caliper Life Sciences, Inc. ... for the third quarter ended September 30, 2011.  Third quarter ... the same period in 2010.  Organic revenue, which excludes the ... over the third quarter of 2010 and 21% on a ...
... University of Technology (QUT) researchers have developed new ... water and aiding clean-up efforts following nuclear disasters. ... of how to clean up millions of tonnes ... safely store the concentrated waste. Professor Huai-Yong ...
Cached Biology Technology:Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease 2Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease 3Caliper Life Sciences Reports Third Quarter 2011 Results 2Caliper Life Sciences Reports Third Quarter 2011 Results 3Caliper Life Sciences Reports Third Quarter 2011 Results 4Caliper Life Sciences Reports Third Quarter 2011 Results 5Caliper Life Sciences Reports Third Quarter 2011 Results 6Caliper Life Sciences Reports Third Quarter 2011 Results 7Caliper Life Sciences Reports Third Quarter 2011 Results 8Caliper Life Sciences Reports Third Quarter 2011 Results 9Caliper Life Sciences Reports Third Quarter 2011 Results 10Caliper Life Sciences Reports Third Quarter 2011 Results 11Caliper Life Sciences Reports Third Quarter 2011 Results 12Caliper Life Sciences Reports Third Quarter 2011 Results 13Caliper Life Sciences Reports Third Quarter 2011 Results 14Caliper Life Sciences Reports Third Quarter 2011 Results 15Caliper Life Sciences Reports Third Quarter 2011 Results 16Caliper Life Sciences Reports Third Quarter 2011 Results 17Caliper Life Sciences Reports Third Quarter 2011 Results 18Caliper Life Sciences Reports Third Quarter 2011 Results 19Technology makes storing radioactive waste safer 2
(Date:4/1/2015)... 1, 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces the second ... is underway to early access pre-order customers. ... at retail outlets including Walmart, Target, AT&T, Dunkin, Donuts, ... was accepted at all outlets and very easy to ...
(Date:3/26/2015)... The Granite Club, Canada,s ... announced it has implemented a state-of-the-art access and security ... and staff, while restricting access to authorized users only. ... IMID Access system because it has the perfect combination ... in addition to unparalleled security," said James DiRenzo ...
(Date:3/23/2015)... 2015 SoundView Technology Group issues a new research ... ) Wocket smart wallet. SoundView was one of the selected user ... with the Wocket in multiple scenarios and outlets. ... other retailers, making both debit and credit card payments.  ... "If the company meets their plans in 2015, it would ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
... of Utah cardiologist proposes as a cause of heart disease ... Health (NIH) likes to seeand reward with one of its ... Ivor J. Benjamin, M.D., professor of internal medicine and biochemistry ... at the U of U School of Medicine, believes that ...
... episodes in the 8000-year history of grapevine cultivation led ... until now. Through biomolecular detective work, German researchers ... varieties in cultivation today. In the process, they have ... and more accurate evaluation of the results, potentially breaking ...
... The National Institute for Mathematical and Biological ... to introduce selected topics in optimal control and ... "Optimal Control and Optimization for Biologists" will be ... University of Tennessee, Knoxville (UTK), campus. The application ...
Cached Biology News:Groundbreaking model of heart disease rewarded with NIH Pioneer Award 2Groundbreaking model of heart disease rewarded with NIH Pioneer Award 3Genetic discovery could break wine industry bottleneck, accelerate grapevine breeding 2Genetic discovery could break wine industry bottleneck, accelerate grapevine breeding 3
... The Vibratome Company has joined forces with ... the Vibratome 411301 Tissue Chopper. This tissue ... sections of tissue for metabolic experiments and ... irregular specimens available at biopsy or from ...
... Antibody Capture Kit eliminates ... optimization steps typically required ... This kit enables the ... multiple antigens based on ...
Without sodium bicarbonate. Sterile, Cell culture tested...
... Custom Peptide Services offer a full ... your research needs. Services include: Peptide ... Peptide synthesis, purified product (70-95% ... (acetylation, amidation, biotinylation, fluorescein, myristylation, phosphorylation, and ...
Biology Products: